a Department of Obstetrics and Gynecology , The Second Hospital of Hebei Medical University , Shijiazhuang , China.
b Department of Gynecologic Oncology , Tianjin Medical University Cancer Institute and Hospital , Tianjin , China.
J Drug Target. 2019 Aug;27(7):709-723. doi: 10.1080/1061186X.2018.1505894. Epub 2019 Feb 21.
In the past several years, competing endogenous RNAs (ceRNAs) have emerged as a potential class of post-transcriptional regulators that alter gene expression through a microRNA (miRNA)-mediated mechanism. An increasing number of studies have found that ceRNAs play important roles in tumorigenesis. Cervical cancer is one of the most common cancers in female malignancies. Despite advances in our understanding of this neoplasm, patients with advanced cervical cancer still have poor prognosis. There is an urgent need to provide a new insight on the mechanism of cervical cancer development and may be acted as new anticancer therapeutic strategies. Here, we review the ceRNA studies and coherent researches in cervical cancer, especially in long non-coding RNA (lncRNA) and miRNAs in order to broaden horizons into mechanisms, selection biomarkers for diagnosis as well as predicting prognosis, and targeting treatment for cervical cancer in the future.
在过去的几年中,竞争内源性 RNA(ceRNA)作为一种潜在的转录后调控因子出现,通过 microRNA(miRNA)介导的机制改变基因表达。越来越多的研究发现 ceRNA 在肿瘤发生中发挥重要作用。宫颈癌是女性恶性肿瘤中最常见的癌症之一。尽管我们对这种肿瘤的认识有所提高,但晚期宫颈癌患者的预后仍然很差。迫切需要对宫颈癌的发展机制提供新的认识,并可能作为新的抗癌治疗策略。在这里,我们综述了 ceRNA 在宫颈癌中的研究和相关研究,特别是长链非编码 RNA(lncRNA)和 miRNA,以期拓宽机制、选择诊断标志物以及预测预后的视野,并为宫颈癌的靶向治疗提供未来的方向。